BioStem Technologies, Inc. (OTCMKTS:BSEM) Sees Significant Increase in Short Interest

BioStem Technologies, Inc. (OTCMKTS:BSEM) saw a significant increase in short interest in the month of October. As of October 31st, there was short interest totalling 115,100 shares, an increase of 22.3% from the October 15th total of 94,100 shares. Based on an average daily trading volume, of 124,800 shares, the short-interest ratio is presently 0.9 days.

BioStem Technologies Stock Down 25.5 %

BSEM traded down 5.95 during trading on Friday, hitting 17.41. 257,100 shares of the stock were exchanged, compared to its average volume of 33,599. The firm has a market capitalization of $289.35 million, a P/E ratio of 25.60 and a beta of -0.36. BioStem Technologies has a 1-year low of 2.34 and a 1-year high of 28.26. The stock has a fifty day moving average price of 13.43 and a two-hundred day moving average price of 10.69.

BioStem Technologies (OTCMKTS:BSEM) last released its quarterly earnings results on Tuesday, November 12th. The company reported 0.32 EPS for the quarter, topping the consensus estimate of 0.31 by 0.01. The firm had revenue of 82.56 million for the quarter, compared to analyst estimates of 78.22 million. Analysts predict that BioStem Technologies will post 1.13 EPS for the current year.

About BioStem Technologies

BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.